SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Harris & Harris Group (TINY)
TINY 1.3100.0%Apr 3 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RockyBalboa who wrote (65)12/21/2001 3:04:07 PM
From: Crossy  Read Replies (1) of 142
 
Well - HHGP seems to be one of the few publicly trading "pure play" nanotech companies out there (besides CRDN, NANX, ALTI) and it looks like a VERY EARLY ENTRY opportunity. Stock has been moving over the last 2 days..

biz.yahoo.com

Currently trading at $2.15. Outstanding : 9.06m, Float : around 6m. Company has the policy to buy back shares on the open market when the stock price is below its Net Asset Value (NAV). The current discount (30%) is huge and looks like a good cushion for this otherwise very volatile type of investment ("incubator").

HHP invests in early stage venture opportunities, especially into nanotech-related businesses. Currently trades at $2.15 - Huge discount to its Net Asset Value (slightly below $3.00)

quote.yahoo.com
biz.yahoo.com

Harris & Harris Group Reports Net Asset Value of $2.92 Per Share as of September 30, 2001
NEW YORK--(BUSINESS WIRE)--Oct. 17, 2001--Harris & Harris Group, Inc.(NASDAQ/NMS SYMBOL: HHGP - news) announced today that its unaudited net asset value and net asset value per share (NAV) at September 30, 2001, were $25,922,620 and $2.92, respectively.

Most of the reduction in net asset value in the third quarter ended September 30, 2001, was owing to declines in value of the Company's publicly held holdings in Nanophase Technologies Corporation (Nasdaq: NANX - news) and Genomica Corporation (Nasdaq: GNOM - news) prior to the Company's complete sale of those holdings in the third quarter. These sales took place prior to September 11, 2001. Nanophase and Genomica had been private equity investments of the Company prior to their initial public offerings in November 1997 and September 2000, respectively.

To date, the tragic events of September 11, 2001, have not had a significant overall measurable effect on the value of the Company's private equity holdings. However, we are mindful that the aftershocks of the September 11 disaster are still working their way through the economy and that the vulnerability to economic shocks of thinly capitalized, high technology, start-up companies with negative cash flows is always high. Thus, it may well be that the full negative effects on the Company's private equity portfolio of September 11 lie ahead. Meanwhile, the Company has maintained liquidity for working capital, follow-on investments and new private equity investments. Cash and equivalents at September 30, 2001, totaled $14,158,263.

After repurchasing 200,000 shares of its common stock late in the third quarter, Harris & Harris Group now has 8,864,231 common shares outstanding. Since 1998, the Company has repurchased a total of 1,859,047 of its common shares. The Company is a Business Development Company. Detailed information about the Company and its holdings can also be found on its website at www.hhgp.com.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext